Researchers examined survival outcomes based on recipient-donor sex constellation after liver transplant for liver cancer.

SBRT showed superiority over radiofrequency ablation in local progression-free survival and tumor control in small HCC but ...

With better risk stratification, clinicians may be able to optimize medical management of patients with chronic HBV who don’t ...

Liver cancer is the fastest rising cancer killer in Britain and below a nurse revealed the four symtoms she experienced ...

CURE spoke with an expert about the potential positive effects of radiation therapy for patients with hepatocellular carcinoma.

Adding durvalumab and bevacizumab to transarterial chemoembolization improved responses and progression-free survival.

The following is a summary of “Lenvatinib and immune-checkpoint inhibitors in hepatocellular carcinoma: mechanistic insights, ...

Yang Zhang, PhD, and Jinjun Shi, PhD, both of the Center for Nanomedicine and Department of Anesthesiology, Perioperative and ...

Researchers at Mount Sinai have made a breakthrough in treating a type of liver cancer called hepatocellular carcinoma (HCC).

Exelixis (EXEL) stock in focus as U.S. FDA leaves out an AdCom in its review of the firm's label expansion for cancer therapy ...

Liver cells attempt to shut down as a defense mechanism against cancer, but this strategy is not particularly effective.

The advent of immunotherapy based on immune checkpoint inhibitors has improved the treatment of advanced hepatocellular ...